Document your current hair condition with photos, including the hairline, part line, crown, and temples
This is supportive, not curative
Bandyopadhyay S, Das S, Samajdar SS, Joshi SR
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for the treatment of type 2 diabetes mellitus (under brand names Ozempic and Rybelsus) and chronic weight management (Wegovy)
Whether this is because of the limit of detection of the neuroprotection assays, or because the semaglutide-induced neuroprotective effects were already maximal, needs to be investigated further
GLP-1 agonists: A review for emergency clinicians